CFCynthia Fernández-Pomares

Cynthia Fernández-Pomares

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cynthia Fernández-Pomares has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mannich bases of hydroxycoumarins: synthesis, DFT/QTAIM computational study and assessment of biological activity

    by J. Sergio Durand-Niconoff, Erik Ortiz-Blanco, Gabriela Sosa-Ortiz, José L. Olivares-Romero, Enrique Juárez-Aguilar, Eva Luz Montoya-Hernández, Cynthia Fernández-Pomares, Ricardo Tovar-Miranda, María Eugenia Castro, Francisco J. Melendez, et al.

    Mannich bases derived from hydroxycoumarins as interesting scaffolds for several applications.


  • Open Access

    Efecto del estrés agudo prepuberal sobre la próstata: Histología y expresión de OB-R, PRL-R, IL-6 y NFkB en la rata

    by Deissy Herrera-Covarrubias, Carlos A. Pérez-León, Cynthia Fernández-Pomares, Genaro A. Coria-Avila, Viridiana Sánchez-Zavaleta, Gonzalo E. Aranda-Abreu, Jorge Suárez-Medellín, Fausto Rojas-Durán, María Elena Hernández.

    El estrés aumenta los niveles séricos de leptina y prolactina, lo cual puede facilitar la proliferación, diferenciación y supervivencia celular implicadas en el desarrollo del cáncer. Se exploró el efecto del estrés prepuberal agudo inducido por una inyección de lipopolisacárido de E. coli (LPS) sobre los cambios histológicos en la próstata dorsolateral (PDL) y ventral (PV) y sobre la expresión de receptores de leptina (OB-R), prolactina (PRL-R), factor nuclear kB (NF-kB) e interleucina 6 (IL-6). Previo al inicio de la pubertad en el día posnatal 35, un grupo experimental de machos recibió una única inyección de LPS (1.5 mg/kg) y el grupo control recibió solución salina. Para confirmar la eficacia del LPS se evaluó la presencia de ptosis, piloerección, letargia, acurrucamiento y cifosis en ambos grupos durante 48 h. En el día posnatal 90 las ratas se sacrificaron para determinar la histología de la próstata (tinción con hematoxilina y eosina) y los receptores se analizaron mediante la técnica de Western Blot. En el periodo prepuberal solo los animales tratados con LPS mostraron signos de enfermedad durante las primeras 24 h post inyección. En la edad adulta expresaron lesiones en la PDL y PV, así como un incremento del área alveolar en PV y un menor número de receptores para el PRL-R corto de 50 kD. Como conclusión se determinó que una única inyección de LPS durante el periodo prepuberal modifica las características histológicas y moleculares de la próstata de la rata, lo cual adiciona información para explicar el efecto del estrés sobre el desarrollo de patologías como el cáncer. Stress can increase the serum levels of leptin and prolactin, which in turn, can facilitate cell proliferation, differentiation and survival, implicated in cancer development. Herein, we explored the main effects of exposure to a single event of acute prepuberal stress induced by the injection of E. coli lipopolysaccharide (LPS) on histological changes in the dorsolateral (DLP) and ventral (VP) prostate, and on the expression of receptors for leptin (OB-R), prolactin (PRL-R), nuclear factor kB (NF-kB), and interleukin 6 (IL-6). Before the start of puberty (PND 35) one group of experimental males received a single injection of lipopolysaccharide (LPS, 1.5 mg/kg) whereas the control group received saline. To confirm the efficacy of LPS rats were monitored for ptosis, piloerection, lethargy, cuddling and kyphosis during 48 h after injection. At PND 90 the rats were euthanized for prostate histology (hematoxylin and eosin stain) and receptors were analyzed by western blots. During the prepuberal test only LPS males expressed signs of sickness during 24 h. In adulthood, LPS males expressed histological prostatic lesions in DLP and VP, and larger alveoli area in VP. Those males also expressed less PRL-R 50 kD receptors in VP. One single exposure to LPS during the prepuberal period can modify histological and molecular features of the rat’s prostate, which in turn, can help explain the effects of stress on the development of prostatic pathologies such as cancer. Keywords: Stress; prostate; cancer; prolactin; puberty, LPS.

  • Hydroalcoholic extract of the widely used Mexican plant Justicia spicigera Schltdl. exerts a cytostatic effect on LNCaP prostate cancer cells

    by Cynthia Fernández-Pomares, Enrique Juárez-Aguilar, Miguel Ángel Domínguez-Ortiz, Janeth Gallegos-Estudillo, Deissy Herrera-Covarrubias, Alberto Sánchez-Medina, Gonzalo E. Aranda-Abreu, Jorge Manzo, María Elena Hernández


  • Open Access

    LONG-TERM ADMINISTRATION OF PROLACTIN OR TESTOSTERONE INDUCED SIMILAR PRECANCEROUS PROSTATE LESIONS IN RATS

    by D Herrera-Covarrubias, G A Coria-Avila, P Chavarría Xicoténcatl, C Fernández-Pomares, J Manzo, G E Aranda-Abreu, M E Hernández

    Evidence indicates that prolactin plays a crucial role in the normal function and development of the prostate, but abnormal high levels of the hormone are associated with hyperplasia and cancer of the gland. Aims: The present study was designed to describe the progressive specific histological abnormalities in the prostate of rats with chronic hyperprolactinemia. Material and Methods: Prolactin was administered during 4; 12 or 24 weeks, and the resulting prostatic alterations were compared with control rats, and also with those treated with testosterone, or the combination of prolactin + testosterone. Results: Rats treated with prolactin, testosterone or prolactin + testosterone expressed precancerous histological abnormalities in the dorsolateral and ventral portions of the prostate as early as in 4 weeks of treatment, but in all cases the malignancy increased after 12 or 24 weeks of treatment. Conclusion: Our study confirms that chronic hyperprolactinemia is a cause of prostate precancerous pathologies.


  • Open Access

    DENV-2 subunit proteins fused to CR2 receptor-binding domain (P28)-induces specific and neutralizing antibodies to the Dengue virus in mice

    by Jazmín García-Machorro, Moisés López-González, Olivia Barrios-Rojas, Cynthia Fernández-Pomares, Claudia Sandoval-Montes, Leopoldo Santos-Argumedo, Nicolás Villegas-Sepúlveda, Benito Gutiérrez-Castañeda, Leticia Cedillo-Barrón

    Domain III (DIII) of the dengue virus (DENV) envelope (E) protein induces strong neutralizing type-specific antibodies. In addition, a region near the fusion loop in domain II (DII) induces the production of cross-reactive antibodies with neutralizing potential. Thus, this study aimed to generate DENV-2 recombinant fusion proteins (i.e., rEII*EIII and rEII*EIII/NS1*) either alone or fused to 3 copies of P28, the minimum CR2-binding domain of the complement protein C3d. The 4 recombinant proteins were generated in a Drosophila melanogaster Schneider 2 (S2) cell system. The expression and secretion of the recombinant proteins were confirmed in vitro using immunofluorescence (IF) and western blot (WB) analyses. Human dengue immune serum samples recognized recombinant proteins. The immunogenicity of the 4 proteins in BALB/c mice was analyzed using ELISA, and the results revealed that the induced specific antibody response was higher in the groups of mice immunized with the P28 fusion proteins. Interestingly, although the 4 recombinant proteins were able to elicit high levels of neutralizing antibodies in BALB/c mice; no adjuvant effect was observed in terms of neutralizing antibodies in the groups immunized with proteins containing P28. Thus, ELISA and PRNT50 assays may evaluate different epitopes and responses, where ELISA showed a wider response that did not always correlate with neutralization. Furthermore, the elicited antibodies were able to recognize the immobilized E glycoprotein of DENV. All mice vaccinated with the DENV-2 recombinant proteins showed induction of higher levels of IgG1 antibodies than of IgG2a antibodies.


  • Growth hormone (GH) is a survival rather than a proliferative factor for embryonic striatal neural precursor cells

    by Citlalli Regalado-Santiago, María Leonor López-Meraz, Juan Santiago-García, Cynthia Fernández–Pomares, Enrique Juárez-Aguilar